As of 2025-07-04, the EV/EBITDA ratio of Flexion Therapeutics Inc (FLXN) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLXN's latest enterprise value is 564.21 mil USD. FLXN's TTM EBITDA according to its financial statements is -78.25 mil USD. Dividing these 2 quantities gives us the above FLXN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 13.4x | 12.8x |
| Forward P/E multiples | 19.6x - 29.4x | 20.6x |
| Fair Price | (91.53) - (64.87) | (79.07) |
| Upside | -465.0% - -358.7% | -415.3% |
| Date | EV/EBITDA |